Yahoo Web Search

Search results

    • Pfizer to Cut Costs in Multi-Year Effort

      Morningstar· 4 days ago

      By Josh Beckerman Pfizer is launching a multi-year cost-reduction program. The company said first phase is focused on operational efficiencies and is expected to deliver savings ...

    • 1 Top Dividend Stock to Load Up On Now | The Motley Fool

      The Motley Fool· 5 days ago

      Amid market turbulence, economic swings, and the ever-changing tides of investor sentiment, dividends have provided a steady income stream, acting as a financial cushion for investors. The takeaway ...

    • AstraZeneca sets sights on $80B in revenue by 2030

      AstraZeneca sets sights on $80B in revenue by 2030

      BioPharma Dive via Yahoo Finance· 6 days ago

      A decade ago, as British drugmaker AstraZeneca fought off a hostile takeover bid by Pfizer, CEO Pascal Soriot made a big promise: The company, he said,...

    • 3 Biotech Stocks to Buy on the Dip: May 2024

      InvestorPlace· 3 days ago

      Despite their exciting growth potential and undeniable rewards, investors have been selling these stocks, causing a slight dip in price. Pfizer (NYSE:PFE) is a giant in biopharma ...